Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive · Last trade price on Jul 7, 2025

Akoya Biosciences Revenue

Akoya Biosciences had revenue of $16.64M in the quarter ending March 31, 2025, a decrease of -9.32%. This brings the company's revenue in the last twelve months to $79.96M, down -14.55% year-over-year. In the year 2024, Akoya Biosciences had annual revenue of $81.67M, down -15.48%.

Revenue (ttm)
$79.96M
Revenue Growth
-14.55%
P/S Ratio
0.80
Revenue / Employee
$390,054
Employees
205
Market Cap
64.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202481.67M-14.96M-15.48%
Dec 31, 202396.63M21.77M29.09%
Dec 31, 202274.86M19.94M36.31%
Dec 31, 202154.92M12.47M29.39%
Dec 31, 202042.44M207.00K0.49%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.